Innovative research will use AI to understand dementia’s linguistic footprint in Latin America

Latin America faces an imminent and daunting challenge: The prevalence of dementia is projected to surge by 180-250% by 2050. Access to a timely and appropriate health system remains a significant hurdle, with an estimated 70-90% of patients in the region left underserved. However, amidst this bleak landscape, advanced technologies, particularly artificial intelligence and natural […]

Santander X Award for TELL

  TELL won the Santander X Uruguay Award 2023, in the startup category. Congratulations to the whole team!  

TELL lands on Behavior Research Methods

A full description of TELL v.1.0.0 has been published in Behavior Research Methods, the main scientific journal on cognitive science methods, techniques, and instrumentation. We are proud to receive this validation from a world-leading expert venue. See the full paper here.

Monumental study to detect linguistic markers of neurodegeneration (in Spanish)

It is well known that most medical studies and clinical trials are conducted in white populations from developed countries. And although the risk of suffering from different diseases depends very closely on socioenvironmental and socioeconomic factors, the same is true for dementias and other neurodegenerative disorders. There are 7000 languages in the world and only […]

Talk at CAEII

Talk on the origins and horizons of TELL during the 21st Argentine Congress of Students of Industrial Engineering and Related Careers.

$8M NIH grant on language and dementia

The Cognitive Neuroscience Center (University of San Andrés, Argentina), together with the ReDLat consortium, will lead the largest study of language, AI, neuroscience and dementia in the region. The project, titled «An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations», is aimed at developing an […]

TELL has become a member of the AABC!

TELL, our speech testing app, has been incorporated into the Alzheimer’s Association Business Consortium. We are excited to team up with notable stakeholders to develop scalable solutions for patients worldwide. For more information on the AABC, click here.